Steven Feldman to Drug Monitoring
This is a "connection" page, showing publications Steven Feldman has written about Drug Monitoring.
Connection Strength
2.862
-
Cohen SR, Pona A, Cline AE, Feldman SR. The complexity of adverse event assessment and counseling for patients on biologic treatment. Expert Rev Clin Immunol. 2019 08; 15(8):809-811.
Score: 0.672
-
Zargari O, Hejazi S, Shahidi-Dadras M, Younespour S, Robati R, Firooz A, Toosi P, Feldman SR. Considerable variation among Iranian dermatologists in the dosing and monitoring of methotrexate for treating psoriasis. Int J Dermatol. 2014 Mar; 53(3):385-9.
Score: 0.452
-
Greenlaw SM, Yentzer BA, O'Neill JL, Balkrishnan R, Feldman SR. Assessing adherence to dermatology treatments: a review of self-report and electronic measures. Skin Res Technol. 2010 May; 16(2):253-8.
Score: 0.355
-
Conde JF, Kaur M, Fleischer AB, Tusa MG, Camacho F, Feldman SR. Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis. Cutis. 2008 May; 81(5):435-41.
Score: 0.309
-
Tusa MG, Ladd M, Kaur M, Balkrishnan R, Feldman SR. Adapting electronic adherence monitors to standard packages of topical medications. J Am Acad Dermatol. 2006 Nov; 55(5):886-7.
Score: 0.276
-
Oussedik E, Patel NU, Cash DR, Gupta AS, Feldman SR. Severe and acute complications of biologics in psoriasis. G Ital Dermatol Venereol. 2017 Dec; 152(6):586-596.
Score: 0.148
-
Ahn CS, Culp L, Huang WW, Davis SA, Feldman SR. Adherence in dermatology. J Dermatolog Treat. 2017 Mar; 28(2):94-103.
Score: 0.135
-
Davis SA, Krowchuk DP, Feldman SR. Prescriptions for a toxic combination: use of methotrexate plus trimethoprim-sulfamethoxazole in the United States. South Med J. 2014 May; 107(5):292-3.
Score: 0.117
-
Semble AL, Davis SA, Feldman SR. Safety and tolerability of tumor necrosis factor-a inhibitors in psoriasis: a narrative review. Am J Clin Dermatol. 2014 Feb; 15(1):37-43.
Score: 0.115
-
West C, Narahari S, O'Neill J, Davis S, Huynh M, Clark A, Boles A, Feldman SR. Adherence to adalimumab in patients with moderate to severe psoriasis. Dermatol Online J. 2013 May 15; 19(5):18182.
Score: 0.110
-
Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007 Jul; 57(1):81-3.
Score: 0.072
-
Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, Fleischer AB, Balkrishnan R, Feldman SR. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007 Feb; 56(2):211-6.
Score: 0.070
-
Hodari KT, Nanton JR, Carroll CL, Feldman SR, Balkrishnan R. Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat. 2006; 17(3):136-42.
Score: 0.016
-
Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004 Aug; 51(2):212-6.
Score: 0.015